Change in Status for the Platelet Aggregation Inhibitors Drug Class

Change in Status for the Platelet Aggregation Inhibitors Drug Class

On May 28, FirstCare temporarily revised the preferred drug list to address reported possible drug shortages of products in the Platelet Aggregation Inhibitors drug class. The change allows providers to prescribe these drugs without requiring a non-preferred prior authorization and people enrolled in Medicaid continued access to necessary medication. A list of the affected drugs is below. This is a temporary change until the preferred products are sufficiently available in the market. Prescribers are encouraged to use the VDP Formulary Search. Click here for covered drugs.
 

NDC Label Name
43598033960 ASPIRIN-DIPYRIDAM ER 25-200 MG
49884000702 ASPIRIN-DIPYRIDAM ER 25-200 MG
62559085060 ASPIRIN-DIPYRIDAM ER 25-200 MG
65162059606 ASPIRIN-DIPYRIDAM ER 25-200 MG
70436009205 ASPIRIN-DIPYRIDAM ER 25-200 MG
68462040560 ASPIRIN-DIPYRIDAM ER 25-200 MG

Send to a Friend

* Required field

Captcha The math problem above is intended to reduce spam.